University of Wisconsin - Madison

Research Study: Antecedent Metabolic Health and Metformin Aging Study (ANTHEM)

Tue, December 05, 2023 7:59 PM | Anonymous member (Administrator)

Principal Investigator: Adam R. Konopka, Ph. D.

Aging is a risk factor for nearly all chronic diseases. The goal of this study is to investigate the effect that metformin, an anti-diabetic medication, has on the aging process in those who are insulin sensitive versus those who are insulin resistant. We are now recruiting people aged 40-75 years old who may be insulin resistant or at risk for type 2 diabetes to participate in the ANTHEM Aging Study.

You may qualify if you have one of the following:

  • Are insulin resistant
  • Have high blood sugar (100-125 mg/dL) or HbA1c (5.7-6.4%)
  • Your doctor has told you that you are at risk of developing type 2 diabetes

If you do not know if you meet these criteria, we can evaluate for free. You may have increased risk of insulin resistance or high blood sugar if you have a BMI >30 kg/m2 or if you are not physically active.

Volunteers will undergo a health screening prior to enrollment. Those with known heart disease, diabetes, bleeding disorders, or other major illnesses do not qualify for the study.

Once admitted, visits may range from 10 minutes to five hours and will include blood and muscle samples, a body composition scan and an insulin sensitivity test. Participants will be compensated for their time, and metformin or placebo will be provided at no cost.

For more information contact our team at:

UWRA is committed to creating an inclusive environment where every member feels a sense of belonging, and where we appreciate and celebrate each other's abilities, views, and accomplishments.

Feedback, questions, website problems - contact us at: 

Copyright © UWRA  2018. All rights reserved.

For More Information Contact UWRA

Executive Director

UW-Madison Retirement Association

21 North Park Street, Room 7205

Madison, WI 53715-1218


Powered by Wild Apricot Membership Software